a
a
Weather:
No weather information available
HomeGood NewsIn Italy there is the only case in the world where the availability of the cellular drug for the treatment of Multiple Sclerosis will no longer be a problem

In Italy there is the only case in the world where the availability of the cellular drug for the treatment of Multiple Sclerosis will no longer be a problem

In Italy there is the only case in the world where the availability of the cellular drug for the treatment of Multiple Sclerosis will no longer be a problem

In Italy there is the only case in the world where the availability of the cellular drug for the treatment of Multiple Sclerosis will no longer be a problem.

 

The stem cells already produced are stored in the GMP workshop (AIFA authorised) of Casa Sollievo della Sofferenza. This is one of the first great results of the study and the first clinical trial conducted by Professor Angelo Vescovi of the University of Milan – Bicocca, Scientific Director of the IRCCS itself, in collaboration with Prof. Stefano Pluchino of the University of Cambridge (UK).

The study was published by the authoritative magazine Cell Stem Cell. The following participated in the experimentation: Casa Sollievo della Sofferenza – San Giovanni Rotondo, Bicocca University of Milan, University of Cambridge, Revert Onlus, Pontificia Accademia Pro Vita, Eoc, Puglia Region.

Brain stem cell transplantation in patients suffering from Secondary Progressive Multiple Sclerosis is safe, very well tolerated and with possible long-lasting and protective effects from further damage to the patients’ brains

No comments

Sorry, the comment form is closed at this time.

Translate »
WP Radio
WP Radio
OFFLINE LIVE